CRISPR Therapeutics is a gene editing specialist. It developed Casgevy, a medicine for two rare blood diseases, in collaboration with Vertex Pharmaceuticals. Casgevy doesn't generate much revenue yet, ...

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...

WASHINGTON — The CIA officer found with $40 million in gold bars stashed at his home is accused of creating a fake top secret intelligence program to receive government funds for his personal ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

For this contest, we are turning our spotlight to the skies, celebrating excellence in every aspect of your journey. From America's best airlines and luxurious airport lounges to the most rewarding ...

A diploma from one of these ace institutions can launch an acting career. Just ask alums like Meryl Streep, Adam Driver and Cynthia Erivo. By Caitlin Huston Business Writer Amid a changing arts ...

Deep Track Capital acquired 168,066 shares of Structure Therapeutics last quarter; the estimated trade size was $11.50 million (based on quarterly average prices). Meanwhile, the quarter-end position ...

Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large ...

The parity between contenders on the diamond is off the charts over the first six weeks of the regular season. Some have suffered from it more than others, and still look like teams that belong in our ...

When you enroll in one of the biotechnology master's degrees at Case Western Reserve University School of Medicine, expect a transformative educational journey that blends rigorous academic coursework ...

AbbVie (ABBV) shares climbed roughly 2% in premarket trading Thursday after the pharma giant raised its full-year earnings outlook on the back of a strong first-quarter revenue beat, and the results ...